Myasthenia gravis and thymus: long-term follow-up screening of thymectomized and non-thymectomized patients
Thymoma screening is recommended at the onset of myasthenia gravis (MG) or when patients with MG present with clinical deterioration or a progressive increase of anti-acetylcholine receptor antibody. However, it is unknown if it is necessary to repeat the screening of thymoma at fixed intervals, even in the absence of MG deterioration, when the initial screening is negative. We analyzed the recurrence rate and incidence of new thymoma in a series of patients with well-controlled MG. The sample consisted of 53 patients, aged 17 to 72 years, and the follow-up varied between 75 and 472 months. The chest computerized tomography detected thymus abnormalities in eight patients at the initial screening and no abnormalities in all patients at a second screening after five years. The findings of this study support the classical opinion that screening for thymoma should be recommended only if there is clinical deterioration due to the disease.
Auteurs principaux: | Lorenzoni,Paulo José, Augusto,Lucas Pires, Kay,Cláudia Suemi Kamoi, Scola,Rosana Herminia, Werneck,Lineu Cesar |
---|---|
Format: | Digital revista |
Langue: | English |
Publié: |
Academia Brasileira de Neurologia - ABNEURO
2013
|
Accès en ligne: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000700462 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Myasthenia gravis and multiple sclerosis: an uncommon presentation
par: Lorenzoni,Paulo J., et autres
Publié: (2008) -
Myasthenia gravis during pregnancy: what care should be taken?
par: Ducci,Renata Dal-Prá, et autres
Publié: (2021) -
Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials
par: LORENZONI,Paulo José, et autres
Publié: (2020) -
Dandy-Walker syndrome in adult mimicking myasthenia gravis
par: Cardoso,Juliana, et autres
Publié: (2007) -
Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
par: Lorenzoni,Paulo José, et autres
Publié: (2022)